Daliresp (roflumilast)
500 ug/1 · Tablet
By AstraZeneca Pharmaceuticals LP
- NDC
- 0310-0095
- Route
- Oral
- Therapeutic class
- Phosphodiesterase 4 Inhibitor , Phosphodiesterase 4 Inhibitors [MoA]
- Marketing category
- NDA
Package sizes
- 30 TABLET in 1 BOTTLE, PLASTIC (0310-0095-30)NDC 0310-0095-30Available to order
- 90 TABLET in 1 BOTTLE, PLASTIC (0310-0095-90)NDC 0310-0095-90Available to order
Additional information
Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.
Request this medication
Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

